Introduction
Glucuronidation plays an essential role in thyroid hormone homeostasis not only by facilitating excretion, but also by providing the first step in enterohepatic recycling of triiodothyronine (T 3 ) and thyroxine (T 4 ) (Visser, 1990; Klaassen, 2001, 2002) . Reductions in serum T 4 and corresponding increases in T 4 glucuronidation occur in rats in response to the anticonvulsant phenobarbital (PB) (McClain et al., 1989) , the selective antagonist of corticotropin-releasing factor receptor-1 DMP 904 (Wong et al., 2005; Lecureux et al., 2009) , the synthetic steroids spironolactone and pregnenolone-16␣-carbonitrile (PCN) (Semler et al., 1989; Liu et al., 1995) , and the polycyclic aromatic hydrocarbons 3-methylcholanthrene (3-MC), tetrachlorodibenzo-p-dioxin (TCDD), and polychlorinated biphenyls (Hood and Klaassen, 2000; Craft et al., 2002) .
Polychlorinated biphenyl (PCB) mixtures such as Aroclor-1254 are especially effective in reducing circulating levels of T 4 in rats (Collins and Capen, 1980; Liu et al., 1995) . Although there are a number of theories regarding the mechanisms by which PCBs exert their effects on thyroid hormones, including direct effects on the gland itself and interference with serum transport proteins (Capen, 1994; Li and Hansen, 1997) , the major focus has been on increased biotransformation. As early as the 1970s, increased glucuronidation of T 4 and increased biliary excretion of T 4 -glucuronide after exposure to Aroclor-1254 were demonstrated (Bastomsky, 1974) . Subsequently, studies with thyroidectomized rats demonstrated that this effect produced by PCBs or TCDD was due to an extrathyroidal mechanism, most likely increased glucuronidation (Barter and Klaassen, 1992; Schuur et al., 1997) . PCB mixtures are produced by random chlorination of the biphenyl molecule, which can theoretically produce 209 different congeners with varying degrees of chlorination and patterns of toxicity (De Voogt and Brinkman, 1989; Li and Hansen, 1997) . The congeners are commonly divided into three types. The coplanar PCB congeners, which have no chlorine substitutions in the ortho positions, have affinity for the aryl hydrocarbon receptor (AhR), induce CYP1A, and are referred to as TCDD-type inducers. The noncoplanar PCB congeners, which have at least two chlorine substitutions in the ortho positions, have low affinity for the AhR (Murk et al., 1996) , induce CYP2B, and are referred to as PB-type inducers. The mono-ortho coplanar PCB congeners have one chlorine substitution in an ortho position, which reduces but does not abolish affinity for the AhR. These congeners induce both CYP1A and CYP2B in rats and are referred to as mixed-type inducers (Safe et al., 1985) .
We have previously shown that individual PCB congeners differentially reduce serum T 4 levels, with the PB-type and mixed-type PCBs being most effective (Martin and Klaassen, 2010) . However, little is known about their ability to affect biliary excretion of T 4 -glucuronide. Thus, the present study was designed to test the hypothesis that the reduction of serum T 4 by these PCBs corresponds with their ability to induce the glucuronidation of T 4 and increase the biliary excretion of T 4 -glucuronide. PCB-126 (3,3Ј4,4Ј,5-pentachlorobiphenyl, a coplanar TCDD-type congener), PCB-95 (2,2Ј,3,5Ј,6-pentachlorobiphenyl, noncoplanar PB-type congener), PCB-99 (2,2Ј,4,4Ј,5-pentachlorobiphenyl, noncoplanar PB-type congener), and PCB-118 (2,3Ј,4,4Ј,5-pentachlorobiphenyl, a mono-ortho coplanar mixed-type congener) were examined. Aroclor-1254 was used to compare the effects of the mixture with those of the congeners. Aroclor-1242 was used to compare the effects of a PCB mixture with a lower (42% by weight) degree of chlorination. TCDD was included as the prototypical AhR ligand for comparison with PCB-126. After a 7-day administration period, radiolabeled T 4 was administered intravenously to the rats, the disappearance of [ 125 I]T 4 from the plasma and excretion into bile was quantified, the radioactive metabolites in bile were separated by high-performance liquid chromatography (HPLC), and the induction of hepatic UDP-glucuronosyltransferase (UGT) activity toward T 4 was determined.
Materials and Methods
Chemicals and Reagents. Aroclor-1254 and Aroclor-1242 were donated by Dr. Lawrence Hansen (University of Illinois at Urbana). TCDD was a gift from Dr. Karl Rozman (University of Kansas Medical Center, Kansas City, KS). PCB-95, PCB-99, PCB-118, and PCB-126 were obtained from AccuStandard (New Haven, CT). Radioimmunoassay kits for assay of serum thyroid hormones were obtained from Diagnostics Products (Los Angeles, CA). Animals and Treatments. The Institutional Animal Care and Use Committee approved all protocols before initiation. Male Sprague-Dawley rats (Sasco, Omaha, NE), weighing 225 to 250 g, were individually housed in hanging wire-bottomed cages and were maintained at approximately 70°F on a 12-h light/dark cycle. All compounds were dissolved in corn oil (Mazola, Best Foods, Englewood Cliffs, NJ). Rats (six per group) were administered the corn oil solutions of Aroclor-1254, Aroclor-1242 (32 mg/kg per day), PCB-95, PCB-99, PCB-118 (16 mg/kg per day), PCB-126 (40 g/kg per day), or TCDD (3.9 g/kg per day) via gavage for 7 consecutive days at a dose volume of 5 ml/kg. The dose selection was based on our dose-response studies of these PCBs (Martin and Klaassen, 2010) . Control rats were administered corn oil (5 ml/kg). All rats had ad libitum access to feed (Purina Rodent Chow, 5001; Purina, St. Louis, MO) and water. Body weights were recorded daily. Twentyfour hours after the last dose, animals were anesthetized with sodium pentobarbital (50 mg/ml), combined with 1:1 potassium iodide (1 mg/ml) at 2 ml/kg to prevent uptake of 125 I into the thyroid. The femoral vein and artery were cannulated (PE 50) and primed with saline or heparinized saline (33 units/ml), respectively. Approximately 1 ml of blood was sampled from the artery from which serum was prepared and stored at Ϫ70°C for further assay. The bile duct was cannulated (PE 10), and the body temperature of each animal was maintained at 37°C using a heat lamp with a rectal thermometer. Ten minutes later, each rat was given 1 ml of [ 125 I]T 4 i.v. at 15 Ci/ml in 10 mM NaOH saline ϩ 1% normal rat serum, and bile was collected on ice at 30-min intervals for 2 h. Fifteen minutes after the start of bile collection and three more times at 30-min intervals, approximately 300-l aliquots of blood were collected from the femoral artery. At the end of the 2-h collection period, the urinary bladder was exposed, and urine was collected by puncture with needle and syringe. The liver was removed, weighed and snap frozen, and stored at Ϫ70°C. Bile and urine volumes were determined gravimetrically. Blood samples were centrifuged for 5 min to collect serum. Two aliquots (20 l each) were taken from the bile, serum, and urine samples for gamma spectroscopy. After the addition of methanol (1:2) and storage at Ϫ20°C for 1 h to precipitate protein, bile was centrifuged at 12,000g (4°C) for 10 min, and the supernatant was collected for analysis by HPLC.
HPLC Analysis. Beckman System Gold equipment and software (version 8.1) consisting of an Autosampler 507, Programmable Solvent Module 126, Radioisotope Detector 171 and 110B Solvent Delivery Module for pumping scintillation cocktail were used for HPLC (Beckman Coulter, Fullerton, CA). Reverse-phase HPLC was performed on a 10 ϫ 0.3 cm ChromSpher C18 column in combination with both a ChromSep 10 ϫ 2 mm reverse-phase guard column (Chrompack, Inc., Raritan, NJ) and a 7.5 ϫ 4.6 mm Adsorbosphere C18 reverse-phase guard column (Alltech Associates, Inc., Deerfield, IL) with a 16 to 45% stepwise linear gradient of acetonitrile run against 0.02 M ammonium acetate, pH 4 for 1 h (Visser et al., 1993b) . The sample volume injected was 20 l. To determine the amount of T 4 -glucuronide present, the percent total area of the T 4 -glucuronide peak was multiplied by the total biliary radioactivity.
Determination of Serum T 4 and T 3 . The concentrations of total (representing free and protein-bound) T 4 and T 3 in serum were determined by radioimmunoassay. The limits of detection of these kits were 0.25 g/dl and 7 ng/dl, respectively.
Microsome Preparation. UGT activity toward T 4 was determined in liver microsomes. Liver microsomes were prepared as described previously (Hood and Klaassen, 2000) . In brief, liver tissue was homogenized in 2 volumes of ice-cold buffer containing 50 mM Tris and 150 mM potassium chloride (pH 7.5). Homogenates were centrifuged at 860g for 15 min, and the pellet was discarded. The supernatant was centrifuged at 23,300g for 25 min at 4°C, and the pellet was discarded. This second supernatant was decanted into ultracentrifuge tubes and was centrifuged at 105,000g for 1 h at 4°C. The resulting pellet was removed and homogenized in 1.15% potassium chloride containing 10 mM neutralized EDTA. The homogenate was centrifuged at 105,000g for 1 h at 4°C. The supernatant was discarded, and the microsomal pellet was homogenized in 0.4 ml/g tissue of 0.25 M sucrose. The homogenate was stored at Ϫ70°C until analysis. Protein concentrations in microsomes were determined according to the bicinchoninic acid method using a commercial assay kit with bovine serum albumin as the standard. dmd.aspetjournals.org initiated by adding 50 l of microsomal protein (final concentration, 250 g/ml) before incubation for 1 h in a 37°C water bath. The reaction was terminated by placing the samples on ice and adding 200 l of ice-cold methanol. The samples were centrifuged at 12,000g (4°C) for 45 min. The supernatant (200 l) was poured over a Sephadex LH-20 column (1-ml bed volume) that had been equilibrated with 6 ml of 0.1 N HCl. Free 125 I was eluted by rinsing the column with 2 ml of 0.1 N HCl. Columns were subsequently rinsed with 2 ml of deionized water. The [
125 I]T 4 -glucuronide was eluted by rinsing with 3 ml of deionized water, and to ensure complete elution of the glucuronide, the columns were rinsed with an additional 3 ml of deionized water. The [
125 I]T 4 that remained unconjugated was eluted from the columns using 3 ml of ethanol: 0.1 N NaOH (1:1 v/v). The amount of [
125 I]T 4 in the eluates was determined by gamma spectroscopy.
Statistics. Differences between control and treated animals were determined using analysis of variance followed by the Duncan's multiple range post hoc test. Significant differences between treated and control groups ( p Ͻ 0.05) are indicated by asterisks in the figures. Statistical analyses were performed using STATISTICA 4.5 (StatSoft, Inc., Tulsa, OK).
Results
No significant changes in body weight were produced by administration of PCBs or TCDD (data not shown). With the exception of PCB-95, all of the treatments produced significant increases in liver/body weight ratios (Fig. 1) . Aroclor-1254 produced the greatest increase of 78%. PCB-99, PCB-118, and TCDD caused roughly equal increases in liver/body weight ratios of 42, 47, and 44%, respectively. Aroclor-1242 and PCB-126 produced more moderate, but still significant, increases in liver/body weight ratios of 33 and 25%, respectively.
The effects of the PCBs on serum thyroid hormone concentrations after the 7-day dosage period are shown in Fig. 2 . Each of the seven treatments produced significant reductions in serum total T 4 (Fig, 2,  top) . The most dramatic reductions in serum T 4 occurred in response to treatment with Aroclor-1254, PCB-99, and PCB-118 (95, 87, and 93%, respectively) . Aroclor-1242, PCB-95, PCB-126, and TCDD caused nearly equal decreases of 73, 64, 74, and 71%, respectively. Serum total T 3 levels were also significantly reduced by each of the compounds (Fig. 2, bottom) . As with T 4 , the largest decreases in T 3 occurred in response to treatment with Aroclor-1254, PCB-99, or PCB-118. These decreases were 53, 41, and 52%, respectively. Aroclor-1242, PCB-95, PCB-126, and TCDD caused decreases of 37, 36, 32, and 17%, respectively.
After the intravenous administration of radiolabeled T 4 ([ 125 I]T 4 ), the concentration of [
125 I]T 4 in serum was determined at 30-min intervals, beginning at 15 min after injection (Fig. 3) The effect of PCBs and TCDD on bile flow was not appreciable (data not shown). Only Aroclor-1242 significantly increased bile flow and only at the 30-and 60-min time points. These increases were 36 and 37%, respectively.
The biliary excretion rate for total [ 125 I]T 4 (T 4 and all metabolites) was significantly increased by Aroclor-1254, PCB-118, PCB-126, and TCDD (Fig. 4) . Aroclor-1254 had the greatest effect, increasing the Fig. 5) . In control animals, the T 4 -glucuronide represented, on average, 86% of the radiolabeled iodothyronines present in bile. Figure 6 shows both the rate (top) and the cumulative amount (bottom) of biliary excretion of T 4 -glucuronide after pretreatment of the rats with the various polychlorinated biphenyls. The effects on the rate of excretion of T 4 -glucuronide were consistent with the effects on the overall rate of excretion of [ 125 I]T 4 (Fig. 4, top) . The rate of biliary excretion of T 4 -glucuronide was significantly increased by Aroclor-1254, PCB-118, PCB-126, and TCDD. Aroclor-1254 was the most effective, causing an average increase of 850% over the 2-h collection period. PCB-118, PCB-126, and TCDD also markedly increased the The amount of [ 125 I]T 4 and its metabolites excreted in urine during the 2-h collection period was only a small percentage (0.8 to 27%) of that present in bile (data not shown). Administration of PCBs and TCDD did not result in significant differences in urinary excretion of [ 125 I]T 4 . The effect of PCBs and TCDD on the activity of UGTs toward T 4 was evaluated in liver microsomes and is shown in Fig. 7 . Aroclor-1254, PCB-126, and TCDD were the most effective inducers of UGT activity toward T 4 , causing 789, 709, and 824% increases, respectively, in UGT activity compared with the control group value. Aroclor-1242 and PCB-118 were slightly less effective, producing increases in activity of 307 and 514%, respectively. PCB-95 and PCB-99 did not significantly increase the activity of UGTs toward T 4 .
Discussion
It is generally thought that the reduction in serum T 4 produced by PCBs is due to increased glucuronidation of T 4 followed by increased biliary excretion of T 4 -glucuronide (Bastomsky, 1974; Hood and Klaassen, 2000; Vansell and Klaassen, 2001; Craft et al., 2002) . However, the present study demonstrates that at least one additional mechanism might be responsible for the reduction in serum T 4 on the basis of the observations that PCB mixtures and congeners used in this study significantly reduced serum levels of T 4 (Fig. 2) , but not all of them significantly increased the in vivo excretion of T 4 -glucuronide into bile (Fig. 4) or increased the UGT activity toward T 4 in vitro (Fig. 7) .
We were not surprised that Aroclor-1254 and TCDD significantly increased the biliary excretion of T 4 -glucuronide in vivo, because it has been reported previously (Bastomsky, 1974; Vansell and Klaassen, 2001 ). However, we were surprised that only the PCB congeners with TCDD-like activity, namely PCB-118 and PCB-126, significantly increased the biliary excretion of T 4 -glucuronide in vivo, whereas the PB-type congeners, PCB-95 and PCB-99, did not. We have shown that PCB-118 and PCB-126 significantly increased CYP1A2 activity [as quantified by ethoxyresorufin-O-deethylase (EROD) activity], whereas PCB-95 and PCB-99 increased CYP1B2 activity [as quantified by pentoxyresorufin-O-deethylase (PROD) activity] (Martin and Klaassen, 2010) .
The effects of PCB congeners on UGT activity toward T 4 in vitro were consistent with the in vivo excretion results. Aroclor-1254, PCB-118, PCB-126, and TCDD were the most effective inducers of UGT activity toward T 4 in vitro. PCB-95 and PCB-99 (PB-type) had no effect on UGT activity toward T 4 . These results are supported by the observation that PCB-110 (a PB-type congener) did not induce hepatic UGT activity unless it was contaminated with PCB-126 (Li et al., 1998) . When a PCB-contaminated soil sample is filtered with charcoal to remove the coplanar (TCDD-like) congeners, induction of UGT activity is abolished (Li and Hansen, 1997) . These data suggest that the ability of the PCBs to induce UGT activity toward T 4 is related to the level of TCDD-like activity of these compounds.
The mechanism by which TCDD induces gene transcription begins by interaction with a soluble cytoplasmic receptor known as the AhR. The ligand (TCDD) and the receptor are then translocated to the nucleus where the heterodimerization with the AhR nuclear translocator occurs. The receptor-ligand complex then interacts with xenobiotic response elements, which are cis-acting DNA sequences that induce transcription of genes (Whitlock, 1993) . Transcriptional regulation of the genes encoding UGT1A6 in rat liver is mediated by xenobiotic response elements, and this gene is inducible by the AhR ligands 3-MC and TCDD (Emi et al., 1996; Masmoudi et al., 1997) . It is currently thought that this UGT isoform is at least partially responsible for glucuronidation of T 4 . Evidence for this includes impaired T 4 glucuronidation in Gunn rats, which have a genetic defect in all UGT1 gene products (Visser et al., 1993a) . In addition, induction of UGT activity toward p-nitrophenol (a specific substrate of UGT1A6) by 3-MC, PCBs, and TCDD also increased the glucuronidation of T 4 but not T 3 (Beetstra et al., 1991; Visser et al., 1993b; van Raaij et al., 1993) . In regard to PCBs, these data support the theory that induction of UGT activity toward T 4 is mediated by the TCDDlike activity of these compounds. This also explains the lack of induction of UGT activity toward T 4 by the PB-type congeners, which do not bind to the AhR (Safe et al., 1985) .
Whereas there appears to be a good correlation between the ability of these PCBs to increase UGT activity toward T 4 in vitro and to increase the excretion of T 4 -glucuronide in vivo, there is not a good correlation with this ability to lower serum T 4 levels. The AhR ligands, Aroclor-1254, PCB-118, PCB-126, and TCDD, were the most effective inducers of UGT activity toward T 4 in vitro and produced the greatest increases in biliary excretion of T 4 -glucuronide in vivo. The PB-type congeners (PCB-95 and PCB-99) did not induce UGT activity toward T 4 in vitro or increase the biliary excretion of T 4 -glucuronide in vivo. According to present theory, one would anticipate that the TCDD-type congeners would decrease serum T 4 the most and the PB-type congeners would not be as effective. However, this hypothesis is not supported by the results of the current study. PCB-99, which was one of the most effective congeners at reducing serum levels of T 4 , did not induce UGT activity toward T 4 or increase the biliary excretion of T 4 -glucuronide. In addition, two of the compounds that increased UGT activity the most were less effective at reducing serum levels of T 4 than PCB-99. This suggests that the PB-like activity of the mixtures and congeners is responsible for perturbation of pathways that are not related to UGT induction. was less than 30% of that of controls (Fig. 3) . (Hennemann et al., 2001) . Several transport proteins have been identified and cloned from rat liver that are thought to mediate the transport of thyroid hormones, including the organic anion-transporting polypeptides Oatp1a1, Oatp1a4, and Oatp1b2, as well as the sodium taurocholate cotransporting polypeptide Ntcp (Docter et al., 1997; Abe et al., 1998; Friesema et al., 1999; Fujiwara et al., 2001) . Treatment of male Sprague-Dawley rats with PB increased Oatp1a4 protein levels in liver and enhanced the uptake of digoxin (substrate for Oatp1a4) (Hagenbuch et al., 2001) . Another study reported the induction of Oatp1a4 protein by PB and PCN (Rausch-Derra et al., 2001 ). These reports reinforce findings in previous studies that pretreatment with PCN and PB increased the hepatic uptake and biliary excretion of cardiac glycosides (Klaassen, 1974) and suggest that the increased hepatic uptake of cardiac glycosides may be due, at least in part, to up-regulation of Oatp1a4.
It is conceivable that PCB-99, PCB-118, and Aroclor-1254, which have PB-like activity (induction of CYP2B) (Martin and Klaassen, 2010) , may also induce Oatp1a4 and increase hepatic uptake of T 4 . In fact, it has been shown that Oatp1a4 protein was increased 130% by PCB-99 but was decreased 72% by PCB-126 (Guo et al., 2002) . If hepatic uptake of T 4 is increased by PCB-99 and decreased in response to PCB-126, this may, at least in part, explain the differential effects of PCB-99 and PCB-126 on serum T 4 . PCB-99 effectively reduces serum T 4 without inducing UGT activity toward T 4 or increasing the biliary excretion of T 4 -glucuronide, whereas PCB-126 is less effective at reducing serum levels of T 4 while significantly inducing UGT activity toward T 4 . The other PB-type congener, PCB-95, also significantly increased the disappearance of [ 125 I]T 4 without inducing UGT activity or increasing the biliary excretion of T 4 -glucuronide. However, PCB-95 was less effective than PCB-99 in decreasing plasma T 4 levels, which probably reflects the more labile, metabolizable structure of PCB-95 (Matthews and Dedrick, 1984) .
The selective antagonist of corticotropin-releasing factor receptor-1, DMP 904, dramatically increased the biliary clearance of unconjugated [
125 I]T 4 in rats, at least in part by enhanced hepatic uptake of [
125 I]T 4 through induction of Oatp1a1 and Oatp1a4 (Wong et al., 2005) . DMP 904 also induced a canalicular transporter, namely the multidrug resistance protein-2 (Mrp2) (Wong et al., 2005) . Further study demonstrated that DMP 904 increased plasma clearance and hepatic uptake of [ 125 I]T 4 in Wistar but not in Mrp2-deficient TR(Ϫ) rats, suggesting that Mrp2 is responsible for biliary excretion of T 4 -glucuronide and contributes in part to the excretion of T 4 (Lecureux et al., 2009) . Sulfation is another pathway for thyroid hormone metabolism (Wu et al., 2005) and contributes a small part to the biliary excretion of T 3 , which was increased by PCN but not by PCB (Vansell and Klaassen, 2002) .
In conclusion, the present study provides evidence that the effects of PCB mixtures and congeners on serum levels of T 4 cannot be explained solely by induction of UGT activity toward T 4 and enhanced excretion of T 4 -glucuronide. There appear to be two major effects of PCBs on serum T 4 . One is increased glucuronidation and increased biliary excretion, which is associated with binding to the AhR, and the second is enhanced tissue uptake, which is associated with the PB-like characteristics of the congeners. Increased glucuronidation facilitates biliary excretion of T 4 -glucuronide; however, it appears that reductions in serum T 4 are more dependent on uptake, probably through transport proteins such as Oatp1a4.
